Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | MMP13 | P45452 | 4/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28661714 | 0.88 | MMP13 (0.40) | NPC1RAB9AL3MBTL1MMP13THRB | |
| SCHEMBL28675126 | 0.79 | NPC1 (0.41) | NPC1RAB9AL3MBTL1MMP13THRB | |
| SCHEMBL23000861 | 0.78 | NPC1 (0.47) | NPC1RAB9AL3MBTL1MMP13THRB | |
| SCHEMBL28688187 | 0.77 | NPC1 (0.47) | NPC1RAB9AL3MBTL1 | |
| SCHEMBL28670949 | 0.76 | NPC1 (0.49) | NPC1RAB9AL3MBTL1MMP13SMN1; SMN2 | |
| SCHEMBL25256941 | 0.76 | NPC1 (0.51) | NPC1RAB9AL3MBTL1MMP13THRB | |
| SCHEMBL28670913 | 0.76 | RAB9A (0.57) | NPC1RAB9AL3MBTL1MMP13THRB | |
| SCHEMBL28661711 | 0.74 | NPC1 (0.35) | NPC1RAB9AL3MBTL1MMP13 | |
| SCHEMBL18234234 | 0.73 | NPC1 (0.55) | NPC1RAB9AL3MBTL1 | |
| SCHEMBL28678652 | 0.73 | NPC1 (0.42) | NPC1RAB9AL3MBTL1MMP13SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107922394-B | 3-tetrazolyl-benzene-1, 2-disulfonamide derivatives as metallo-beta-lactamase inhibitors | 默沙东公司 | 2021-07-13 | — | — | CN | disclosed |